Brief: Jilin Province Huinan Changlong Bio-Pharmacy Posts QTRLY Profit Attributable RMB31.3 MLN
Nov 13 (Reuters) - Jilin Province Huinan Changlong
Bio-pharmacy Co Ltd 8049.HK :
* QTRLY PROFIT ATTRIBUTABLE RMB31.3 MILLION VERSUS RMB34.6
MILLION
* QTRLY TURNOVER RMB154.8 MILLION VERSUS RMB172.7 MILLION
Source text for Eikon: ID:nHKS7b2C5C
Further company coverage: 8049.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Jilin Province Huinan Changlong Bio-pharmacy
See all newsJilin Changlong Bio-pharmacy interim profit rises on lower costs
Brief: Jilin Province Huinan Changlong Bio-pharmacy Posts H1 Revenue Of RMB 435 million
Brief: Jilin Province Huinan Changlong Bio-Pharmacy Profit For Year Attributable Rmb198.9 Million
Brief: Jilin Province Huinan Changlong Bio-Pharmacy Subscribes To ICBC Structured Deposit Product
Brief: Jilin Province Huinan Changlong Bio-Pharmacy Subscribes To ICBC Wealth Management Product For RMB50 MLN